Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus

Clinical and Vaccine Immunology

Volumn 19, Issue 12, 2012, Pages 1980-1983

  Ajami, Nadim J ^a   Barry, Meagan A ^a   Carrillo, Berenice ^a   Muhaxhiri, Zana ^a   Neill, Frederick H ^a   Prasad, B V Venkataram ^a   Opekun, Antone R ^a   Gilger, Mark A ^a   Graham, David Y ^a   Atmar, Robert L ^a   Estes, Mary K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOUSTON VIRUS PROTEASE; HOUSTON VIRUS PROTEASE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; NOROVIRUS PROTEASE; NOROVIRUS PROTEASE ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENZYME;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; GENOTYPE; HOUSTON VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROPREVALENCE; STRAIN DIFFERENCE; STRAIN IDENTIFICATION; VIRAL GASTROENTERITIS; VIRUS GENOME; VIRUS LIKE AGENT; VIRUS STRAIN; VIRUS VIRULENCE;

ADULT; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, VIRAL; HUMAN EXPERIMENTATION; HUMANS; IMMUNOASSAY; NORWALK VIRUS; PEPTIDE HYDROLASES;

EID: 84870463270     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00411-12     Document Type: Review

References (21)

1. Atmar RL, et al. 2011. Norovirus vaccine against experimental human Norwalk virus illness. N. Engl. J. Med. 365:2178-2187.
2. Atmar RL, et al. 2008. Norwalk virus shedding after experimental human infection. Emerg. Infect. Dis. 14:1553-1557.
3. Boucher CA, et al. 1989. Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage. J. Clin. Microbiol. 27:1577-1581. (Pubitemid 19170166)
4. Bull RA, Eden JS, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog. 6:e1000831.doi:10.1371/ journal.ppat.1000831.
5. Chen TH, et al. 2011. Differentiation of foot-and-mouth disease-infected pigs from vaccinated pigs using antibody-detecting sandwich ELISA. J. Vet. Med. Sci. 73:977-984.
6. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361:1776-1785.
7. Graham DY, et al. 1994. Norwalk virus infection of volunteers: new insights based on improved assays. J. Infect. Dis. 170:34-43. (Pubitemid 24186422)
8. Jia XY, Summers DF, Ehrenfeld E. 1992. Host antibody response to viral structural and nonstructural proteins after hepatitis A virus infection. J. Infect. Dis. 165:273-280.
9. Jiang X, Wang M, Wang K, Estes MK. 1993. Sequence and genomic organization of Norwalk virus. Virology 195:51-61.
10. Kabrane-Lazizi Y, Emerson SU, Herzog C, Purcell RH. 2001. Detection of antibodies to HAV 3C proteinase in experimentally infected chimpanzees and in naturally infected children. Vaccine 19:2878-2883. (Pubitemid 32244280)
11. Kavanagh O, et al. 2011. Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin. Vaccine Immunol. 18:1187-1190.
12. Lindesmith L, et al. 2005. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 79:2900-2909. (Pubitemid 40270568)
13. Lindesmith LC, et al. 2010. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J. Virol. 84:1800-1815.
14. Matsui SM, et al. 1991. The isolation and characterization of a Norwalk virus-specific cDNA. J. Clin. Invest. 87:1456-1461.
15. Reeck A, et al. 2010. Serological correlate of protection against norovirus-induced gastroenteritis. J. Infect. Dis. 202:1212-1218.
16. Silberstein E, Kaplan G, Taboga O, Duffy S, Palma E. 1997. Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein. Arch. Virol. 142:795-805. (Pubitemid 27185683)
17. Stewart DR, Morris TS, Purcell RH, Emerson SU. 1997. Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus. J. Infect. Dis. 176:593-601. (Pubitemid 27360522)
18. Tacket CO, Sztein MB, Losonsky GA, Wasserman SS, Estes MK. 2003. Humoral, mucosal, and cellular immune responses to oral Norwalk viruslike particles in volunteers. Clin. Immunol. 108:241-247. (Pubitemid 37117370)
19. Wong SJ, et al. 2003. Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J. Clin. Microbiol. 41:4217-4223. (Pubitemid 37099687)
20. Zeitler CE, Estes MK, Prasad BVV. 2006. X-ray crystallographic structure of the Norwalk virus protease at 1.5-Å resolution. J. Virol. 80:5050-5058.
21. Zheng DP, et al. 2006. Norovirus classification and proposed strain nomenclature. Virology 346:312-323.